GlassScriptPhysician profile
Luxi Wan
NPI 1902434442
$5,497.87
in general payments reported to CMS, 2019-2025
13 companies · $4,788 in 2025
The $4,788 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $23.07 · 2024: $687 · 2025: $4,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,288 · Travel and Lodging: $2,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,287.67 |
| Travel and Lodging | $2,210.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,931.29 | 2025 | Gallant, Merlin@Home, Dragonfly Opstar |
| Abiomed | $489.39 | 2024-2025 | Impella |
| Angiodynamics, INC. | $337.98 | 2024-2025 | Alphavac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $171.31 | 2024 | Corevalve Evolut R, Mycarelink, Azure Xt Dr Mri Surescan |
| Irhythm Technologies, INC. | $170.97 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $124.98 | 2024 | Repatha |
| Cvrx, INC. | $103.57 | 2025 | Barostim Neo System |
| Medical Device Business Services, INC. | $42.75 | 2025 | Vistaseal |
| Bridgebio Pharma, INC. | $41.43 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.65 | 2024 | Jardiance |
| Lantheus Medical Imaging, INC. | $26.47 | 2025 | |
| Ethicon US, LLC | $17.41 | 2025 | Stratafix, Vistaseal, Dermabond |
| Pfizer INC. | $13.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luxi Wan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.